Your browser doesn't support javascript.
loading
Differential Impact of Fractional Flow Reserve Measured After Coronary Stent Implantation by Left Ventricular Dysfunction.
Choi, Ki Hong; Kwon, Woochan; Shin, Doosup; Lee, Seung-Hun; Hwang, Doyeon; Zhang, Jinlong; Nam, Chang-Wook; Shin, Eun-Seok; Doh, Joon-Hyung; Chen, Shao-Liang; Kakuta, Tsunekazu; Toth, Gabor G; Piroth, Zsolt; Hakeem, Abdul; Uretsky, Barry F; Hokama, Yohei; Tanaka, Nobuhiro; Lim, Hong-Seok; Ito, Tsuyoshi; Matsuo, Akiko; Azzalini, Lorenzo; Leesar, Massoud A; Daemen, Joost; Collison, Damien; Collet, Carlos; De Bruyne, Bernard; Koo, Bon-Kwon; Park, Taek Kyu; Yang, Jeong Hoon; Song, Young Bin; Hahn, Joo-Yong; Choi, Seung-Hyuk; Gwon, Hyeon-Cheol; Lee, Joo Myung.
Afiliación
  • Choi KH; Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kwon W; Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Shin D; Division of Cardiology, Department of Internal Medicine, Duke University Medical Center, Durham, North Carolina, USA.
  • Lee SH; Division of Cardiology, Department of Internal Medicine, Heart Center, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Korea.
  • Hwang D; Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Korea.
  • Zhang J; Department of Cardiology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Nam CW; Department of Medicine, Keimyung University Dongsan Medical Center, Daegu, Korea.
  • Shin ES; Department of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
  • Doh JH; Department of Medicine, Inje University Ilsan-Paik Hospital, Goyang, Korea.
  • Chen SL; Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Kakuta T; Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, Ibaraki, Japan.
  • Toth GG; University Heart Centre Graz, Medical University Graz, Austria.
  • Piroth Z; Gottsegen National Cardiovascular Centre, Budapest, Hungary.
  • Hakeem A; Division of Cardiovascular Diseases and Hypertension, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, New Jersey, USA.
  • Uretsky BF; Central Arkansas VA Health System/University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
  • Hokama Y; Department of Cardiology, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan.
  • Tanaka N; Department of Cardiology, Ajou University School of Medicine, Suwon, Korea.
  • Lim HS; Department of Cardio-Renal Medicine and Hypertension, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Ito T; Department of Cardiology, Kyoto Second Red Cross Hospital, Kyoto, Japan.
  • Matsuo A; Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Azzalini L; Division of Cardiovascular Diseases, University of Alabama, Birmingham, Alabama, USA.
  • Leesar MA; Department of Interventional Cardiology, Thoraxcenter, Erasmus University Medical Centre, Rotterdam, the Netherlands.
  • Daemen J; West of Scotland Regional Heart and Lung Centre, Golden Jubilee National Hospital, Glasgow, United Kingdom.
  • Collison D; Cardiovascular Center Aalst, Aalst, Belgium.
  • Collet C; Department of Cardiology, University of Lausanne, Switzerland.
  • De Bruyne B; Department of Cardiology, University of Lausanne, Switzerland.
  • Koo BK; Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Korea.
  • Park TK; Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Yang JH; Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Song YB; Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Hahn JY; Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Choi SH; Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Gwon HC; Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Lee JM; Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
JACC Asia ; 4(3): 229-240, 2024 Mar.
Article en En | MEDLINE | ID: mdl-38463680
ABSTRACT

Background:

Both left ventricular systolic function and fractional flow reserve (FFR) are prognostic factors after percutaneous coronary intervention (PCI). However, how these prognostic factors are inter-related in risk stratification of patients after PCI remains unclarified.

Objectives:

This study evaluated differential prognostic implication of post-PCI FFR according to left ventricular ejection fraction (LVEF).

Methods:

A total of 2,965 patients with available LVEF were selected from the POST-PCI FLOW (Prognostic Implications of Physiologic Investigation After Revascularization with Stent) international registry of patients with post-PCI FFR measurement. The primary outcome was a composite of cardiac death or target-vessel myocardial infarction (TVMI) at 2 years. The secondary outcome was target-vessel revascularization (TVR) and target vessel failure, which was a composite of cardiac death, TVMI, or TVR.

Results:

Post-PCI FFR was independently associated with the risk of target vessel failure (per 0.01 decrease HRadj 1.029; 95% CI 1.009-1.049; P = 0.005). Post-PCI FFR was associated with increased risk of cardiac death or TVMI (HRadj 1.145; 95% CI 1.025-1.280; P = 0.017) among patients with LVEF ≤40%, and with that of TVR in patients with LVEF >40% (HRadj 1.028; 95% CI 1.005-1.052; P = 0.020). Post-PCI FFR ≤0.80 was associated with increased risk of cardiac death or TVMI in the LVEF ≤40% group and with that of TVR in LVEF >40% group. Prognostic impact of post-PCI FFR for the primary outcome was significantly different according to LVEF (Pinteraction = 0.019).

Conclusions:

Post-PCI FFR had differential prognostic impact according to LVEF. Residual ischemia by post-PCI FFR ≤0.80 was a prognostic indicator for cardiac death or TVMI among patients with patients with LVEF ≤40%, and it was associated with TVR among patients with patients with LVEF>40%. (Prognostic Implications of Physiologic Investigation After Revascularization with Stent [POST-PCI FLOW]; NCT04684043).
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: JACC Asia Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: JACC Asia Año: 2024 Tipo del documento: Article